Dr. Rhame is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1221 W Lake St
Suite 201
Minneapolis, MN 55408Phone+1 612-824-1772Fax+1 612-821-4799
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1973 - 1975- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1972 - 1973
University of MichiganResidency, Internal Medicine, 1969 - 1970
Harlem Hospital CenterInternship, Internal Medicine, 1968 - 1969
Columbia University Vagelos College of Physicians and SurgeonsClass of 1968
Certifications & Licensure
CA State Medical License 1972 - Present
MN State Medical License 1979 - 2025
GA State Medical License 1971 - 1972- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Raltegravir Kaletra Pharmacokinetics Start of enrollment: 2007 Nov 01
- Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial Start of enrollment: 2014 Oct 16
Publications & Presentations
PubMed
- 1903 citationsCirculating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a c...Daniel D Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Jacquie Neuhaus
Plos One. 2015-10-14 - 914 citationsThe major genetic determinants of HIV-1 control affect HLA class I peptide presentationFlorencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi
Science. 2010-12-10 - 414 citationsThe safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection a double-blind, pl...Margaret A. Fischl, Douglas D. Richman, N. Hansen, A. C. Collier, J. T. Carey
Annals of Internal Medicine. 1990-05-15
Press Mentions
Health Experts Encourage People to Get New COVID-19 VaccineAugust 23rd, 2024- COVID-19 Persists While Flu Declines in MinnesotaFebruary 2nd, 2023
- Flu, RSV Cases Decline as COVID Remains SteadyDecember 29th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
